These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21180577)

  • 1. Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.
    Bartels C; Späte K; Krampe H; Ehrenreich H
    Ther Adv Neurol Disord; 2008 Nov; 1(3):193-206. PubMed ID: 21180577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition.
    Ehrenreich H; Bartels C; Sargin D; Stawicki S; Krampe H
    J Ren Nutr; 2008 Jan; 18(1):146-53. PubMed ID: 18089462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.
    Sirén AL; Fasshauer T; Bartels C; Ehrenreich H
    Neurotherapeutics; 2009 Jan; 6(1):108-27. PubMed ID: 19110203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.
    Ehrenreich H; Fischer B; Norra C; Schellenberger F; Stender N; Stiefel M; Sirén AL; Paulus W; Nave KA; Gold R; Bartels C
    Brain; 2007 Oct; 130(Pt 10):2577-88. PubMed ID: 17728357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
    Cervellini I; Ghezzi P; Mengozzi M
    Methods Mol Biol; 2013; 982():163-73. PubMed ID: 23456868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
    Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
    J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
    Schreiber K; Magyari M; Sellebjerg F; Iversen P; Garde E; Madsen CG; Börnsen L; Romme Christensen J; Ratzer R; Siebner HR; Laursen B; Soelberg Sorensen P
    Mult Scler; 2017 Apr; 23(5):675-685. PubMed ID: 27481206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice.
    Hagemeyer N; Boretius S; Ott C; Von Streitberg A; Welpinghus H; Sperling S; Frahm J; Simons M; Ghezzi P; Ehrenreich H
    Mol Med; 2012 May; 18(1):628-35. PubMed ID: 22396019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic growth factor EPO has neuro-protective and neuro-trophic effects--review].
    Zhou ZY; Yang M; Fok TF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):332-7. PubMed ID: 15854305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.
    Gao Y; Mengana Y; Cruz YR; Muñoz A; Testé IS; García JD; Wu Y; Rodríguez JC; Zhang C
    J Histochem Cytochem; 2011 Feb; 59(2):214-27. PubMed ID: 21339183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonhematopoietic variants of erythropoietin in ischemic stroke: need for step-wise proof-of-concept studies.
    Hermann DM
    ScientificWorldJournal; 2010 Nov; 10():2285-7. PubMed ID: 21103797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Beneficial Effect of Brief Erythropoietin Peptide JM4 Therapy on Chronic Relapsing EAE.
    Gaindh D; Choi YB; Marchese M; Dowling P; Cook S; Blumberg B; Park JH; Lu W
    Neurotherapeutics; 2021 Jan; 18(1):401-411. PubMed ID: 32959273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.
    Shin T; Ahn M; Moon C; Kim S
    Anat Cell Biol; 2012 Dec; 45(4):215-20. PubMed ID: 23301189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial and Cellular Expression Patterns of Erythropoietin-Receptor and Erythropoietin during a 42-Day Post-Lesional Time Course after Graded Thoracic Spinal Cord Impact Lesions in the Rat.
    Cohrs G; Goerden S; Lucius R; Synowitz M; Mehdorn HM; Held-Feindt J; Knerlich-Lukoschus F
    J Neurotrauma; 2018 Feb; 35(3):593-607. PubMed ID: 28895456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of erythropoietin therapy on experimental autoimmune encephalomyelitis.
    Zhang X; Li QY; Xiao BG
    Int J Neurosci; 2012 May; 122(5):255-62. PubMed ID: 22176555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.
    Cho GW; Koh SH; Kim MH; Yoo AR; Noh MY; Oh S; Kim SH
    Brain Res; 2010 Sep; 1353():1-13. PubMed ID: 20547143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.
    Yuan R; Maeda Y; Li W; Lu W; Cook S; Dowling P
    PLoS One; 2008 Apr; 3(4):e1924. PubMed ID: 18382691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia.
    Rodríguez Cruz Y; Mengana Támos Y; Muñoz Cernuda A; Subirós Martines N; González-Quevedo A; Sosa Testé I; García Rodríguez JC
    ScientificWorldJournal; 2010 Nov; 10():2288-300. PubMed ID: 21103798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
    Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
    World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.